Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCCR
Schwab Core Bond ETF
SCCR
|
+$623M |
| 2 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$608M |
| 3 |
Applovin
APP
|
+$402M |
| 4 |
Amazon
AMZN
|
+$340M |
| 5 |
Lockheed Martin
LMT
|
+$307M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$542M |
| 2 |
JPMorgan Chase
JPM
|
+$289M |
| 3 |
HES
Hess
HES
|
+$275M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$266M |
| 5 |
ANSS
Ansys
ANSS
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.34% |
| 2 | Financials | 11.49% |
| 3 | Consumer Discretionary | 9.42% |
| 4 | Healthcare | 9.25% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SI
3376
Shoulder Innovations Inc
SI
$409M
| $148K | ﹤0.01% |
+11,779
| New | +$165K |
|
|
CLPR
3377
Clipper Realty
CLPR
$47M
| $145K | ﹤0.01% |
38,207
| – | – |
|
3378
Skillsoft
SKIL
$84.4M
| $145K | ﹤0.01% |
11,108
| – | – |
|
3379
Rhinebeck Bancorp
RBKB
$195M
| $129K | ﹤0.01% |
11,327
| – | – |
|
3380
Ispire Technology
ISPR
$99.9M
| $120K | ﹤0.01% |
46,700
+148
| +0.3% | +$430 |
|
|
ARAI
3381
Arrive AI Inc
ARAI
$14M
| $119K | ﹤0.01% |
32,821
+10,196
| +45% | +$67.6K |
|
3382
Cabaletta Bio
CABA
$455M
| $119K | ﹤0.01% |
50,824
+203
| +0.4% | +$348 |
|
|
SAFX
3383
XCF Global Inc
SAFX
$180M
| $117K | ﹤0.01% |
+89,675
| New | +$131K |
|
3384
OPAL Fuels
OPAL
$74.7M
| $117K | ﹤0.01% |
53,148
-5,715
| -10% | -$13.5K |
|
3385
Cognition Therapeutics
CGTX
$97M
| $115K | ﹤0.01% |
+84,940
| New | +$116K |
|
3386
InfuSystem Holdings
INFU
$248M
| $110K | ﹤0.01% |
10,655
| – | – |
|
3387
Neonode
NEON
$16.4M
| $107K | ﹤0.01% |
30,796
| – | – |
|
3388
Ring Energy
REI
$357M
| $106K | ﹤0.01% |
97,106
+531
| +0.5% | +$481 |
|
|
TGEN
3389
Tecogen Inc
TGEN
$121M
| $106K | ﹤0.01% |
+12,000
| New | +$96.2K |
|
|
MGRM
3390
DELISTED
Monogram Orthopaedics
MGRM
| $106K | ﹤0.01% |
+18,000
| New | +$96.1K |
|
3391
Genelux
GNLX
$119M
| $105K | ﹤0.01% |
25,000
| – | – |
|
3392
Sagimet Biosciences
SGMT
$588M
| $103K | ﹤0.01% |
15,000
| – | – |
|
3393
Siebert Financial
SIEB
$68.8M
| $103K | ﹤0.01% |
35,189
| – | – |
|
|
ACTU
3394
Actuate Therapeutics
ACTU
$24.2M
| $98.8K | ﹤0.01% |
14,765
| – | – |
|
3395
Veritone
VERI
$139M
| $96.6K | ﹤0.01% |
20,040
+40
| +0.2% | +$116 |
|
3396
MediciNova
MNOV
$65M
| $90.1K | ﹤0.01% |
71,506
| – | – |
|
3397
AXT Inc
AXTI
$4.83B
| $89.8K | ﹤0.01% |
+20,000
| New | +$57.2K |
|
3398
INmune Bio
INMB
$57.7M
| $86.6K | ﹤0.01% |
41,825
-10,000
| -19% | -$22.9K |
|
3399
Upexi
UPXI
$58.9M
| $86.5K | ﹤0.01% |
15,000
| – | – |
|
3400
Amplify Energy
AMPY
$186M
| $86K | ﹤0.01% |
16,376
| – | – |
|
Similar funds
Charles Schwab's Q3 2025 Portfolio in Review
As of Q3 2025, Charles Schwab held 3,560 positions worth $626B, up 8.3% from $578B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 4.8%. Charles Schwab opened 66 new positions and exited 105, leaving the 3,560-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- Charles Schwab's largest Q3 2025 buy was BitMine Immersion Technologies: 1,712,780 shares worth $88.9M.
- Charles Schwab added most to Schwab Core Bond ETF in Q3 2025, an estimated $623M increase.
- Charles Schwab's biggest Q3 2025 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $542M.
- Charles Schwab fully exited Hess in Q3 2025, selling an estimated $275M.
- Charles Schwab's ten largest holdings make up 25% of its $626B portfolio in Q3 2025.
- Charles Schwab opened 66 new positions and closed 105 in Q3 2025.
- Charles Schwab's portfolio value rose 8.3% quarter-over-quarter to $626B.
Based on Charles Schwab's 13F filing for Q3 2025, filed 10 Nov 2025.